Arena gets $35 million cash injection from Deerfield
This article was originally published in Scrip
Executive Summary
Hard on the heels of announcing a scheduled panel meeting date for advisers to the FDA to review its weight management treatment lorcaserin, Arena Pharmaceuticals has secured around $35 million in funding through an equity placement with Deerfield Management.